Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Koilocytosis.

Krause KA, Butler SL.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2018 Dec 1.

2.

Anal Intraepithelial Neoplasia from a Pathologists Point of View.

Lyons KM, Butler SL.

Clin Colon Rectal Surg. 2018 Nov;31(6):328-335. doi: 10.1055/s-0038-1668102. Epub 2018 Nov 2. Review.

3.

High Grade Squamous Intraepithelial Lesion (HSIL).

Khieu M, Butler SL.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Apr 2.

4.

Modified mRNA Vaccines Protect against Zika Virus Infection.

Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS.

Cell. 2017 Mar 23;169(1):176. doi: 10.1016/j.cell.2017.03.016. No abstract available.

5.

Pseudo-outbreak of Brevundimonas diminuta Attributed to Contamination of Culture Medium Supplement.

Lee RA, Moser SA, Long M, Butler SL, Whiddon JF, Camins BC.

Infect Control Hosp Epidemiol. 2017 May;38(5):598-601. doi: 10.1017/ice.2017.17. Epub 2017 Mar 7.

PMID:
28264729
6.

Modified mRNA Vaccines Protect against Zika Virus Infection.

Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS.

Cell. 2017 Mar 9;168(6):1114-1125.e10. doi: 10.1016/j.cell.2017.02.017. Epub 2017 Feb 17. Erratum in: Cell. 2017 Mar 23;169(1):176.

7.

Image of the month: Pseudomelanosis duodeni and Strongyloides stercoralis.

Cochet AE, Cunningham JR, Butler SL.

Am J Gastroenterol. 2015 Dec;110(12):1651. doi: 10.1038/ajg.2015.113. No abstract available.

PMID:
26673486
8.

2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment.

Patera AC, Butler SL, Cinque P, Clifford DB, Elston R, Garcea RL, Major EO, Pavlovic D, Peterson IS, Ryan AM, Tyler KL, Weber T; PML Consortium.

J Neurovirol. 2015 Dec;21(6):702-5. doi: 10.1007/s13365-015-0392-5. No abstract available.

PMID:
26501778
9.

Utility of reflexive gomori methenamine silver and Acid-fast bacillus staining on bronchoalveolar lavage specimens.

Strenge KS, Kunkel JE, George AA, Mailhiot T, Butler SL.

Lab Med. 2015 Winter;46(1):4-7. doi: 10.1309/LMLJHG4E2UZKD7RG.

PMID:
25617385
10.

Artificial tektites: an experimental technique for capturing the shapes of spinning drops.

Baldwin KA, Butler SL, Hill RJ.

Sci Rep. 2015 Jan 7;5:7660. doi: 10.1038/srep07660.

11.

Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.

Shi J, Zhou J, Halambage UD, Shah VB, Burse MJ, Wu H, Blair WS, Butler SL, Aiken C.

J Virol. 2015 Jan;89(1):208-19. doi: 10.1128/JVI.01411-14. Epub 2014 Oct 15.

12.

Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.

Balasubramanian V, Solapure S, Shandil R, Gaonkar S, Mahesh KN, Reddy J, Deshpande A, Bharath S, Kumar N, Wright L, Melnick D, Butler SL.

Antimicrob Agents Chemother. 2014 Jul;58(7):4185-90. doi: 10.1128/AAC.00137-14. Epub 2014 May 12.

13.

Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.

Balasubramanian V, Solapure S, Iyer H, Ghosh A, Sharma S, Kaur P, Deepthi R, Subbulakshmi V, Ramya V, Ramachandran V, Balganesh M, Wright L, Melnick D, Butler SL, Sambandamurthy VK.

Antimicrob Agents Chemother. 2014;58(1):495-502. doi: 10.1128/AAC.01903-13. Epub 2013 Nov 4.

14.

Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients.

Chisholm-Burns MA, Spivey CA, Sredzinski E, Butler SL.

J Am Pharm Assoc (2003). 2012;52(6):816-22. doi: 10.1331/JAPhA.2012.11083.

PMID:
23229970
15.

Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.

Waki K, Durell SR, Soheilian F, Nagashima K, Butler SL, Freed EO.

PLoS Pathog. 2012;8(11):e1002997. doi: 10.1371/journal.ppat.1002997. Epub 2012 Nov 8.

16.

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy.

Butler SL, Valdez H, Westby M, Perros M, June CH, Jacobson JM, Levy Y, Cooper DA, Douek D, Lederman MM, Tebas P.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):297-303. doi: 10.1097/QAI.0b013e31822ccfcc. Review.

PMID:
21792065
17.

Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.

Johnson TW, Tanis SP, Butler SL, Dalvie D, Delisle DM, Dress KR, Flahive EJ, Hu Q, Kuehler JE, Kuki A, Liu W, McClellan GA, Peng Q, Plewe MB, Richardson PF, Smith GL, Solowiej J, Tran KT, Wang H, Yu X, Zhang J, Zhu H.

J Med Chem. 2011 May 12;54(9):3393-417. doi: 10.1021/jm200208d. Epub 2011 Apr 13.

PMID:
21446745
18.

Evaluation of p16INK4a immunohistochemical reactivity in endocervical glandular neoplasia.

Monroe M, Wilkinson EJ, Butler SL.

J Low Genit Tract Dis. 2011 Jan;15(1):1-5. doi: 10.1097/LGT.0b013e3181f0b8da.

PMID:
21192168
19.

HIV capsid is a tractable target for small molecule therapeutic intervention.

Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R, Cao J, Ciaramella G, Isaacson J, Jackson L, Hunt R, Kjerrstrom A, Nieman JA, Patick AK, Perros M, Scott AD, Whitby K, Wu H, Butler SL.

PLoS Pathog. 2010 Dec 9;6(12):e1001220. doi: 10.1371/journal.ppat.1001220.

20.

Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK.

Tanis SP, Plewe MB, Johnson TW, Butler SL, Dalvie D, DeLisle D, Dress KR, Hu Q, Huang B, Kuehler JE, Kuki A, Liu W, Peng Q, Smith GL, Solowiej J, Tran KT, Wang H, Yang A, Yin C, Yu X, Zhang J, Zhu H.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7429-34. doi: 10.1016/j.bmcl.2010.10.022. Epub 2010 Oct 13.

PMID:
21036042
21.

A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Murray EJ, Leaman DP, Pawa N, Perkins H, Pickford C, Perros M, Zwick MB, Butler SL.

J Virol. 2010 Jul;84(14):7288-99. doi: 10.1128/JVI.00535-10. Epub 2010 Apr 28.

22.

Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.

Plewe MB, Butler SL, Dress KR, Hu Q, Johnson TW, Kuehler JE, Kuki A, Lam H, Liu W, Nowlin D, Peng Q, Rahavendran SV, Tanis SP, Tran KT, Wang H, Yang A, Zhang J.

J Med Chem. 2009 Nov 26;52(22):7211-9. doi: 10.1021/jm900862n.

PMID:
19873974
23.

New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation.

Blair WS, Cao J, Fok-Seang J, Griffin P, Isaacson J, Jackson RL, Murray E, Patick AK, Peng Q, Perros M, Pickford C, Wu H, Butler SL.

Antimicrob Agents Chemother. 2009 Dec;53(12):5080-7. doi: 10.1128/AAC.00759-09. Epub 2009 Oct 5.

24.

Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.

Iczkowski KA, Butler SL, Shanks JH, Hossain D, Schall A, Meiers I, Zhou M, Torkko KC, Kim SJ, MacLennan GT.

Hum Pathol. 2008 Feb;39(2):275-81. Epub 2007 Nov 28. Erratum in: Hum Pathol. 2013 Dec;44(12):2873.

PMID:
18045648
25.

The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.

Butler SL, Dong H, Cardona D, Jia M, Zheng R, Zhu H, Crawford JM, Liu C.

Lab Invest. 2008 Jan;88(1):78-88. Epub 2007 Nov 19.

26.

Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.

Blair WS, Cao J, Jackson L, Jimenez J, Peng Q, Wu H, Isaacson J, Butler SL, Chu A, Graham J, Malfait AM, Tortorella M, Patick AK.

Antimicrob Agents Chemother. 2007 Oct;51(10):3554-61. Epub 2007 Jul 23.

28.

Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone.

Watchman CJ, Bourke VA, Lyon JR, Knowlton AE, Butler SL, Grier DD, Wingard JR, Braylan RC, Bolch WE.

J Nucl Med. 2007 Apr;48(4):645-54.

29.

Ovarian cancer symptom index: possibilities for earlier detection.

Black SS, Butler SL, Goldman PA, Scroggins MJ.

Cancer. 2007 Jan 15;109(2):167-9. No abstract available.

30.

New immunohistochemical markers in testicular tumors.

Iczkowski KA, Butler SL.

Anal Quant Cytol Histol. 2006 Aug;28(4):181-7. Review.

PMID:
16927637
31.

Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.

Westby M, Nakayama GR, Butler SL, Blair WS.

Antiviral Res. 2005 Sep;67(3):121-40. Review.

PMID:
16112209
32.

Bacterial adhesion to bisphosphonate coated hydroxyapatite.

Ganguli A, Steward C, Butler SL, Philips GJ, Meikle ST, Lloyd AW, Grant MH.

J Mater Sci Mater Med. 2005 Apr;16(4):283-7.

PMID:
15803271
33.

Highly parallel SNP genotyping.

Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, Gunderson KL, Hansen M, Steemers F, Butler SL, Deloukas P, Galver L, Hunt S, McBride C, Bibikova M, Rubano T, Chen J, Wickham E, Doucet D, Chang W, Campbell D, Zhang B, Kruglyak S, Bentley D, Haas J, Rigault P, Zhou L, Stuelpnagel J, Chee MS.

Cold Spring Harb Symp Quant Biol. 2003;68:69-78. No abstract available.

PMID:
15338605
34.

Reduced intracortical inhibition and facilitation of corticospinal neurons in musicians.

Nordstrom MA, Butler SL.

Exp Brain Res. 2002 Jun;144(3):336-42. Epub 2002 Apr 13.

PMID:
12021815
35.
36.
37.

Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M, Martin SL, Bushman FD.

EMBO J. 2001 Jun 15;20(12):3272-81.

38.

A quantitative assay for HIV DNA integration in vivo.

Butler SL, Hansen MS, Bushman FD.

Nat Med. 2001 May;7(5):631-4.

PMID:
11329067
39.

Task-dependent control of human masseter muscles from ipsilateral and contralateral motor cortex.

Butler SL, Miles TS, Thompson PD, Nordstrom MA.

Exp Brain Res. 2001 Mar;137(1):65-70.

PMID:
11310173
40.

Motor cortical control of human masticatory muscles.

Nordstrom MA, Miles TS, Gooden BR, Butler SL, Ridding MC, Thompson PD.

Prog Brain Res. 1999;123:203-14.

PMID:
10635717
42.

The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.

Greenwald J, Le V, Butler SL, Bushman FD, Choe S.

Biochemistry. 1999 Jul 13;38(28):8892-8.

PMID:
10413462
43.
44.

Interstitial fluid flow in tendons or ligaments: a porous medium finite element simulation.

Butler SL, Kohles SS, Thielke RJ, Chen C, Vanderby R Jr.

Med Biol Eng Comput. 1997 Nov;35(6):742-6.

PMID:
9538555
45.
46.
47.

Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Butler SL, Doherty CJ, Hughes JE, Nelson JW, Govan JR.

J Clin Microbiol. 1995 Apr;33(4):1001-4.

48.

Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.

Simpson IN, Finlay J, Winstanley DJ, Dewhurst N, Nelson JW, Butler SL, Govan JR.

J Antimicrob Chemother. 1994 Sep;34(3):353-61.

PMID:
7530242
49.

Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.

Butler SL, Nelson JW, Poxton IR, Govan JR.

FEMS Immunol Med Microbiol. 1994 May;8(4):285-92.

PMID:
7520313
50.

Virulence factors of Burkholderia cepacia.

Nelson JW, Butler SL, Krieg D, Govan JR.

FEMS Immunol Med Microbiol. 1994 Feb;8(2):89-97. Review. No abstract available.

PMID:
7513590

Supplemental Content

Loading ...
Support Center